(Q39996845)

16 September 2017

Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines (English)

1 reference

16 September 2017

cervix uterine cancer

1 reference

Jaehyouk Lee

1

1 reference

16 September 2017

Young Soo Yoon

series ordinal

2

1 reference

16 September 2017

Jae Hoon Chung

series ordinal

3

1 reference

16 September 2017

language of work or name

English

0 references

publication date

2 April 2008

1 reference

16 September 2017

1 reference

16 September 2017

109

1 reference

16 September 2017

2

1 reference

16 September 2017

270-274

1 reference

Activation of the canonical Wnt pathway during genital keratinocyte transformation: a model for cervical cancer progression.

16 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.034

Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.034

Combination analysis of hypermethylated Wnt-antagonist family genes as a novel epigenetic biomarker panel for bladder cancer detection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.034

Inactivation of Wnt inhibitory factor-1 (WIF1) expression by epigenetic silencing is a common event in breast cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.034

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.034

Kremen proteins are Dickkopf receptors that regulate Wnt/beta-catenin signalling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.034

Epigenetic inactivation of the Wnt antagonist DICKKOPF-1 (DKK-1) gene in human colorectal cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.034

A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.034

Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.034

The fundamental role of epigenetic events in cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.034

Cytoplasmic/nuclear expression without mutation of exon 3 of the beta-catenin gene is frequent in the development of the neoplasm of the uterine cervix

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.034

Epigenetic gene silencing in cancer – a mechanism for early oncogenic pathway addiction?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.034

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.034

Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2008.01.034

10.1016/J.YGYNO.2008.01.034

7 January 2021

Identifiers

DOI

1 reference

16 September 2017

1 reference